Massachusetts General Hospital;Hematology/ Oncology — Boston, Massachusetts

Massachusetts General Hospital;Hematology/ Oncology is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital;Hematology/ Oncology has participated in 5 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer, Malignant Melanoma, Advanced BRAFV600 Wild-type Melanoma.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital;Hematology/ Oncology?

Massachusetts General Hospital;Hematology/ Oncology has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital;Hematology/ Oncology conducted?

Massachusetts General Hospital;Hematology/ Oncology has 5 clinical trials on record. Their work covers Non-Small Cell Lung Cancer, Malignant Melanoma, Advanced BRAFV600 Wild-type Melanoma.

Is Massachusetts General Hospital;Hematology/ Oncology accredited by Crixeo Health?

Massachusetts General Hospital;Hematology/ Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital;Hematology/ Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.